Loading...
Header Logo
Keywords
Last Name
Institution

GREGORY N FULLER

TitleProfessor
InstitutionMD Anderson
DepartmentPathology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Elshafeey N, Kotrotsou A, Hassan A, Elshafei N, Hassan I, Ahmed S, Abrol S, Agarwal A, El Salek K, Bergamaschi S, Acharya J, Moron FE, Law M, Fuller GN, Huse JT, Zinn PO, Colen RR. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun. 2019 Jul 18; 10(1):3170. PMID: 31320621.
      View in: PubMed
    2. Santos-Pinheiro F, Penas-Prado M, Kamiya-Matsuoka C, Waguespack SG, Mahajan A, Brown P, Shah K, Fuller GN, Mccutcheon I. Treatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol. 2019 Jul 01. PMID: 31349217.
      View in: PubMed
    3. Georgescu MM, Li Y, Islam MZ, Notarianni C, Sun H, Olar A, Fuller GN. Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications. Oncotarget. 2019 Jun 18; 10(40):4038-4052. PMID: 31258848.
      View in: PubMed
    4. Marisetty AL, Lu L, Veo BL, Liu B, Coarfa C, Kamal MM, Kassem DH, Irshad K, Lu Y, Gumin J, Henry V, Paulucci-Holthauzen A, Rao G, Baladandayuthapani V, Lang FF, Fuller GN, Majumder S. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019 Jun 10; 21(6):775-785. PMID: 30953587.
      View in: PubMed
    5. Ballester LY, Moghadamtousi SZ, Leeds NE, Huse JT, Fuller GN. Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases. Acta Neuropathol Commun. 2019 Apr 29; 7(1):63. PMID: 31036092.
      View in: PubMed
    6. Zheng S, Alfaro-Munoz K, Wei W, Wang X, Wang F, Eterovic AK, Shaw KRM, Meric-Bernstam F, Fuller GN, Chen K, Verhaak RG, Mills GB, Yung WKA, Weathers SP, de Groot JF. Prospective Clinical Sequencing of Adult Glioma. Mol Cancer Ther. 2019 May; 18(5):991-1000. PMID: 30926639.
      View in: PubMed
    7. Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging. Neuro Oncol. 2019 Mar 18; 21(4):527-536. PMID: 30657997.
      View in: PubMed
    8. Olar A, Tran D, Mehta VP, Reinhardt A, Manekia JH, Garnovskaya M, Ellezam B, Luthra R, Sulman EP, Mohila CA, Campbell GA, Powell SZ, Fuller GN, Aldape KD, Adesina AM. ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clin Neuropathol. 2019 Mar/Apr; 38(2):59-73. PMID: 30499772.
      View in: PubMed
    9. Latha K, Yan J, Yang Y, Gressot LV, Kong LY, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Eric Davis R, Huang S, Fuller GN, Rao A, Heimberger AB, Li S, Rao G. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. J Natl Cancer Inst. 2019 Mar 01; 111(3):292-300. PMID: 29947810.
      View in: PubMed
    10. Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado M. RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report. Cancer Genet. 2019 Feb; 231-232:41-45. PMID: 30803556.
      View in: PubMed
    11. Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018 Dec 01; 129(6):1446-1455. PMID: 29328002.
      View in: PubMed
    12. Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, Grami Z, Kong LY, Ling X, Caruso H, Zhou S, Wang YA, Fuller GN, Huse J, Gilboa E, Kang N, Huang X, Verhaak R, Li S, Heimberger AB. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. J Clin Invest. 2019 Jan 02; 129(1):137-149. PMID: 30307407.
      View in: PubMed
    13. Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SF. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359. PMID: 30236511.
      View in: PubMed
    14. Ballester LY, Dunbar E, Guha-Thakurta N, Henson JW, Chandler H, Watkins J, Fuller GN. Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted. Front Neurol. 2018; 9:700. PMID: 30210430.
      View in: PubMed
    15. Lu L, Marisetty A, Liu B, Kamal MM, Gumin J, Veo B, Cai Y, Kassem DH, Weng C, Maynard ME, Hood KN, Fuller GN, Pan ZZ, Cykowski MD, Dash PK, Majumder S. REST overexpression in mice causes deficits in spontaneous locomotion. Sci Rep. 2018 Aug 14; 8(1):12083. PMID: 30108242.
      View in: PubMed
    16. Raza SM, Bell D, Freeman JL, Grosshans DR, Fuller GN, DeMonte F. Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival. Oper Neurosurg (Hagerstown). 2018 08 01; 15(2):131-143. PMID: 29040778.
      View in: PubMed
    17. Du D, Yuan J, Ma W, Ning J, Weinstein JN, Yuan X, Fuller GN, Liu Y. Clinical significance of FBXO17 gene expression in high-grade glioma. BMC Cancer. 2018 Jul 31; 18(1):773. PMID: 30064493.
      View in: PubMed
    18. Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, de Groot JF, Baladandayuthapani V, Sulman EP, Kumar AJ, Sawaya R, Lang FF, Piwnica-Worms D, Colen RR. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 Dec 15; 24(24):6288-6299. PMID: 30054278.
      View in: PubMed
    19. Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248. PMID: 30046660.
      View in: PubMed
    20. Beechar VB, Zinn PO, Heck KA, Fuller GN, Han I, Patel AJ, Ropper AE. Spinal Epidermoid Tumors: Case Report and Review of the Literature. Neurospine. 2018 Jun; 15(2):117-122. PMID: 29991240.
      View in: PubMed
    21. Boulter TD, Sadaka A, Nakawah MO, Smith SV, Alouch N, Berry SE, Whyte AT, Fuller GN, Lee AG. Primary Central Nervous System Lymphoma With Light Chain Deposition Disease (Aggregoma). J Neuroophthalmol. 2018 Jun; 38(2):195-197. PMID: 29280764.
      View in: PubMed
    22. Wang B, Gogia B, Fuller GN, Ketonen LM. Embryonal Tumor with Multilayered Rosettes, C19MC-Altered: Clinical, Pathological, and Neuroimaging Findings. J Neuroimaging. 2018 Sep; 28(5):483-489. PMID: 29797626.
      View in: PubMed
    23. Pilié P, Hasanov E, Matin SF, Woodson AHH, Marcott VD, Bird S, Slack RS, Fuller GN, McCutcheon IE, Jonasch E. Pilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget. 2018 May 04; 9(34):23390-23395. PMID: 29805741.
      View in: PubMed
    24. Ballester LY, Boghani Z, Baskin DS, Britz GW, Olsen R, Fuller GN, Powell SZ, Cykowski MD. Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins. Brain Pathol. 2018 11; 28(6):1012-1019. PMID: 29509313.
      View in: PubMed
    25. Ballester LY, Penas-Prado M, Leeds NE, Huse JT, Fuller GN. FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia. Cold Spring Harb Mol Case Stud. 2018 04; 4(2). PMID: 29610389.
      View in: PubMed
    26. Lewis GD, Jonasch E, Shah AY, Fuller GN, Farach AM, Butler EB, Teh BS. Renal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literature. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e262-e265. PMID: 29706304.
      View in: PubMed
    27. Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, Prabhu SS, Rao G, Fuller GN, Aldape KD, Gumin J, Vence LM, Wistuba I, Rodriguez-Canales J, Villalobos PA, Dirven CMF, Tejada S, Valle RD, Alonso MM, Ewald B, Peterkin JJ, Tufaro F, Fueyo J. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018 05 10; 36(14):1419-1427. PMID: 29432077.
      View in: PubMed
    28. Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, Dunner K, Zal MA, Burks JK, Gumin J, Nwajei F, Rezavanian A, Zhou S, Rao G, Sawaya R, Fuller GN, Huse JT, Antel JP, Li S, Cooper L, Sulman EP, Chen C, Geula C, Kalluri R, Zal T, Heimberger AB. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology. 2018; 7(4):e1412909. PMID: 29632728.
      View in: PubMed
    29. Gilbert AR, Zaky W, Gokden M, Fuller CE, Ocal E, Leeds NE, Fuller GN. Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin. Pediatr Neurosurg. 2018; 53(1):59-63. PMID: 29131126.
      View in: PubMed
    30. Bell AH, DeMonte F, Raza SM, Rhines LD, Tatsui CE, Prieto VG, Fuller GN, Bell D. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas. Virchows Arch. 2018 Mar; 472(3):489-497. PMID: 28844110.
      View in: PubMed
    31. Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, Tong X, Tannir NM, Matin SF, Rathmell WK, Fuller GN, McCutcheon IE, Walker CL, Wang J, Jonasch E. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326. PMID: 28807937.
      View in: PubMed
    32. Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. Am J Dermatopathol. 2017 Jul; 39(7):545-547. PMID: 28178009.
      View in: PubMed
    33. Ballester LY, Huse JT, Tang G, Fuller GN. Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results. Hum Pathol. 2017 11; 69:15-22. PMID: 28549927.
      View in: PubMed
    34. Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 2017 05 01; 19(5):660-668. PMID: 28453745.
      View in: PubMed
    35. Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger AB. Serum microRNA profiling in patients with glioblastoma: a survival analysis. Mol Cancer. 2017 03 11; 16(1):59. PMID: 28284220.
      View in: PubMed
    36. Powell RT, Olar A, Narang S, Rao G, Sulman E, Fuller GN, Rao A. Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas. J Pathol Inform. 2017; 8:9. PMID: 28382223.
      View in: PubMed
    37. Ballester LY, Fuller GN, Powell SZ, Sulman EP, Patel KP, Luthra R, Routbort MJ. Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors. J Neuropathol Exp Neurol. 2017 03 01; 76(3):179-188. PMID: 28395087.
      View in: PubMed
    38. Gressot LV, Doucette T, Yang Y, Fuller GN, Manyam G, Rao A, Latha K, Rao G. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma. Oncotarget. 2017 Feb 21; 8(8):12695-12704. PMID: 27074575.
      View in: PubMed
    39. Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol. 2017 Feb; 92(2):155-160. PMID: 27874212.
      View in: PubMed
    40. Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao WT, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RGW, DePinho RA. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 2016 11 17; 167(5):1281-1295.e18. PMID: 27863244.
      View in: PubMed
    41. Shingu T, Ho AL, Yuan L, Zhou X, Dai C, Zheng S, Wang Q, Zhong Y, Chang Q, Horner JW, Liebelt BD, Yao Y, Hu B, Chen Y, Fuller GN, Verhaak RG, Heimberger AB, Hu J. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nat Genet. 2017 01; 49(1):75-86. PMID: 27841882.
      View in: PubMed
    42. Al Sannaa G, Watson KL, Olar A, Wang WL, Fuller GN, McCutcheon I, Torres KE, Lazar AJ. Sarcoma Brain Metastases: 28 Years of Experience at a Single Institution. Ann Surg Oncol. 2016 12; 23(Suppl 5):962-967. PMID: 27646022.
      View in: PubMed
    43. Bell D, Raza SM, Bell AH, Fuller GN, DeMonte F. Whole-transcriptome analysis of chordoma of the skull base. Virchows Arch. 2016 Oct; 469(4):439-49. PMID: 27401718.
      View in: PubMed
    44. Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger AB. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol. 2016 10; 18(10):1357-66. PMID: 27370400.
      View in: PubMed
    45. Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, Rakopoulos P, Ramaswamy V, Taccone MS, Mischel PS, Fuller GN, Hawkins C, Stanford WL, Taylor MD, Zadeh G, Rutka JT. PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Res. 2016 08 15; 76(16):4708-19. PMID: 27325644.
      View in: PubMed
    46. Phillips LM, Zhou X, Cogdell DE, Chua CY, Huisinga A, R Hess K, Fuller GN, Zhang W. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies. J Pathol. 2016 07; 239(3):355-64. PMID: 27125842.
      View in: PubMed
    47. Mandel JJ, Cachia D, Liu D, Wilson C, Aldape K, Fuller G, de Groot JF. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54. PMID: 27270908.
      View in: PubMed
    48. Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian XW, Yang W, Zhang J, Yemelyanova A, Malpica A, Zhang Z, Fuller GN, Liu J. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56. PMID: 26990854.
      View in: PubMed
    49. Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang S. miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis. Cancer Res. 2016 07 15; 76(14):4293-304. PMID: 27246830.
      View in: PubMed
    50. Verla T, Thomas JG, Thomazy V, Fuller GN, Shaibani A, Omeis I. Fulminant spinal cord compression caused by postradiation inflammatory pseudotumor with rapid response to steroids: case report. J Neurosurg Spine. 2016 Nov; 25(5):660-664. PMID: 27231814.
      View in: PubMed
    51. Park SY, Piao Y, Thomas C, Fuller GN, de Groot JF. Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma. Oncotarget. 2016 May 03; 7(18):26793-805. PMID: 27050366.
      View in: PubMed
    52. Ji P, Zhou X, Liu Q, Fuller GN, Phillips LM, Zhang W. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Oncotarget. 2016 Apr 26; 7(17):23521-9. PMID: 26993778.
      View in: PubMed
    53. Yust-Katz S, Fuller G, Fichman-Horn S, Michaeli N, Inbar E, Lukman J, Limon D, Steiner I, Siegal T. Progressive diffuse meningioangiomatosis: Response to bevacizumab treatment. Neurology. 2016 04 26; 86(17):1643-4. PMID: 27029633.
      View in: PubMed
    54. Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016; 1(2). PMID: 26973881.
      View in: PubMed
    55. Kong LY, Wei J, Fuller GN, Schrand B, Gabrusiewicz K, Zhou S, Rao G, Calin G, Gilboa E, Heimberger AB. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. Oncoimmunology. 2016 May; 5(5):e1117739. PMID: 27467917.
      View in: PubMed
    56. Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, Ivan C, Fuller GN, Gilbert MR, Overwijk W, Calin GA, Heimberger AB. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol. 2016 05; 18(5):639-48. PMID: 26658052.
      View in: PubMed
    57. Liang L, Zhang Y, Malpica A, Ramalingam P, Euscher ED, Fuller GN, Liu J. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol. 2015 Dec; 28(12):1613-20. PMID: 26564007.
      View in: PubMed
    58. Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, Suki D, Colman H, Bhat KP, Sulman EP, Aldape K, Colen RR, Verhaak RG, Lu Z, Fuller GN, Huang S, Lang FF, Sawaya R, Hegi M, Majumder S. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112. PMID: 26558781.
      View in: PubMed
    59. Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JF. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10. PMID: 26354773.
      View in: PubMed
    60. Liu Q, Liu Y, Li W, Wang X, Sawaya R, Lang FF, Yung WK, Chen K, Fuller GN, Zhang W. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathol. 2015 Oct; 130(4):587-97. PMID: 26323991.
      View in: PubMed
    61. Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks JK, Fuller GN, Calin GA, Conrad CA, Creasy C, Ritthipichai K, Radvanyi L, Heimberger AB. PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 2016 Feb; 18(2):195-205. PMID: 26323609.
      View in: PubMed
    62. Saade R, Hessel A, Ginsberg L, Fuller G, Bell D. Primary extradural meningioma presenting as a neck mass: Case report and review of the literature. Head Neck. 2015 Aug; 37(8):E92-5. PMID: 25251307.
      View in: PubMed
    63. Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang J. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98. PMID: 26061751.
      View in: PubMed
    64. Lau SK, Cykowski MD, Desai S, Cao Y, Fuller GN, Bruner J, Okazaki I. Primary rhabdomyosarcoma of the pineal gland. Am J Clin Pathol. 2015 May; 143(5):728-33. PMID: 25873508.
      View in: PubMed
    65. Edson MA, Fuller GN, Allen PK, Levine NB, Ghia AJ, Mahajan A, Brown PD, DeMonte F, Li J. Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. World Neurosurg. 2015 Jul; 84(1):76-81. PMID: 25749579.
      View in: PubMed
    66. Turner KM, Sun Y, Ji P, Granberg KJ, Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, Shmulevich I, Yung WK, Fuller GN, Zhang W. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression. Proc Natl Acad Sci U S A. 2015 Mar 17; 112(11):3421-6. PMID: 25737557.
      View in: PubMed
    67. Phillips J, Tihan T, Fuller G. Practical molecular pathology and histopathology of embryonal tumors. Surg Pathol Clin. 2015 Mar; 8(1):73-88. PMID: 25783823.
      View in: PubMed
    68. Hamilton JD, Lin J, Ison C, Leeds NE, Jackson EF, Fuller GN, Ketonen L, Kumar AJ. Dynamic contrast-enhanced perfusion processing for neuroradiologists: model-dependent analysis may not be necessary for determining recurrent high-grade glioma versus treatment effect. AJNR Am J Neuroradiol. 2015 Apr; 36(4):686-93. PMID: 25500312.
      View in: PubMed
    69. Cachia D, Prado MP, Theeler B, Hamilton J, McCutcheon I, Fuller GN. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11. PMID: 24986181.
      View in: PubMed
    70. Kong LY, Wei J, Haider AS, Liebelt BD, Ling X, Conrad CA, Fuller GN, Levine NB, Priebe W, Sawaya R, Heimberger AB. Therapeutic targets in subependymoma. J Neuroimmunol. 2014 Dec 15; 277(1-2):168-75. PMID: 25465288.
      View in: PubMed
    71. Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD. Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol. 2015 May; 25(3):266-75. PMID: 25040885.
      View in: PubMed
    72. Gressot LV, Doucette TA, Yang Y, Fuller GN, Heimberger AB, Bögler O, Rao A, Latha K, Rao G. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis. Int J Cancer. 2015 May 01; 136(9):2047-54. PMID: 25302990.
      View in: PubMed
    73. Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P. International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014 Sep; 24(5):429-35. PMID: 24990071.
      View in: PubMed
    74. Davoudi S, Anderlini P, Fuller GN, Kontoyiannis DP. A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case. Mycopathologia. 2014 Dec; 178(5-6):465-70. PMID: 25086667.
      View in: PubMed
    75. Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 24974128.
      View in: PubMed
    76. Mukherjee M, Byrd T, Brawley VS, Bielamowicz K, Li XN, Merchant F, Maitra S, Sumazin P, Fuller G, Kew Y, Sun D, Powell SZ, Ahmed N, Zhang N, Pati D. Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme. J Neurooncol. 2014 Aug; 119(1):27-35. PMID: 24792645.
      View in: PubMed
    77. Gabrusiewicz K, Liu D, Cortes-Santiago N, Hossain MB, Conrad CA, Aldape KD, Fuller GN, Marini FC, Alonso MM, Idoate MA, Gilbert MR, Fueyo J, Gomez-Manzano C. Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget. 2014 Apr 30; 5(8):2208-20. PMID: 24809734.
      View in: PubMed
    78. Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang W. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628. PMID: 24747968.
      View in: PubMed
    79. Doucette T, Latha K, Yang Y, Fuller GN, Rao A, Rao G. Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas. Neuro Oncol. 2014 Sep; 16(9):1220-8. PMID: 24676140.
      View in: PubMed
    80. Yust-Katz S, Anderson MD, Liu D, Wu J, Yuan Y, Olar A, Fuller GN, Brown PD, de-Groot JF. Clinical and prognostic features of adult patients with gangliogliomas. Neuro Oncol. 2014 Mar; 16(3):409-13. PMID: 24305706.
      View in: PubMed
    81. Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, de Groot JF. Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res. 2014 Jan 01; 20(1):187-98. PMID: 24240114.
      View in: PubMed
    82. Pong WW, Walker J, Wylie T, Magrini V, Luo J, Emnett RJ, Choi J, Cooper ML, Griffith M, Griffith OL, Rubin JB, Fuller GN, Piwnica-Worms D, Feng X, Hambardzumyan D, DiPersio JF, Mardis ER, Gutmann DH. F11R is a novel monocyte prognostic biomarker for malignant glioma. PLoS One. 2013; 8(10):e77571. PMID: 24147027.
      View in: PubMed
    83. George AA, Fuller GN, Langford LA, Simon CD, Zingalis AA, Mathis DA. Unusual presentation of a granular cell astrocytoma. Histopathology. 2013 Dec; 63(6):883-5. PMID: 24102930.
      View in: PubMed
    84. Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26. PMID: 23636127.
      View in: PubMed
    85. Tahmasebi FC, Farmer P, Powell SZ, Aldape KD, Fuller GN, Patel S, Hollis P, Chalif D, Eisenberg MB, Li JY. Brain metastases from papillary thyroid carcinomas. Virchows Arch. 2013 Apr; 462(4):473-80. PMID: 23532501.
      View in: PubMed
    86. Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter M. Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol. 2013 Feb; 229(3):449-59. PMID: 23007860.
      View in: PubMed
    87. Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, Li X, Gumin J, Zheng H, Hu L, Yli-Harja O, Haapasalo H, Visakorpi T, Liu X, Liu CG, Sawaya R, Fuller GN, Chen K, Lang FF, Nykter M, Zhang W. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest. 2013 Feb; 123(2):855-65. PMID: 23298836.
      View in: PubMed
    88. Hightower E, Cabanillas ME, Fuller GN, McCutcheon IE, Hess KR, Shah K, Waguespack SG, Corley LJ, Devin JK. Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas. Pituitary. 2012 Dec; 15(4):556-61. PMID: 22120760.
      View in: PubMed
    89. Theeler BJ, Yung WK, Fuller GN, De Groot JF. Moving toward molecular classification of diffuse gliomas in adults. Neurology. 2012 Oct 30; 79(18):1917-26. PMID: 23109653.
      View in: PubMed
    90. Gadgil N, Kupferman M, Smitherman S, Fuller GN, Rao G. Curvularia brain abscess. J Clin Neurosci. 2013 Jan; 20(1):173-5. PMID: 22989791.
      View in: PubMed
    91. de Groot J, Liang J, Kong LY, Wei J, Piao Y, Fuller G, Qiao W, Heimberger AB. Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma. Oncotarget. 2012 Sep; 3(9):1036-48. PMID: 23013619.
      View in: PubMed
    92. Yeung SC, Elsayem A, Fuller GN, Lu G, You MJ. Fatal acute monocytic leukaemia with t(6;11) (q27;q23) translocation and KRAS mutation. J Clin Pathol. 2013 Jan; 66(1):73-5. PMID: 22923764.
      View in: PubMed
    93. Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathol. 2012 Sep; 124(3):449-51. PMID: 22772980.
      View in: PubMed
    94. Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, Bögler O, Heimberger AB, Rao G. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol. 2012 Sep; 14(9):1136-45. PMID: 22753228.
      View in: PubMed
    95. Das CM, Taylor P, Gireud M, Singh A, Lee D, Fuller G, Ji L, Fangusaro J, Rajaram V, Goldman S, Eberhart C, Gopalakrishnan V. The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation. Oncogene. 2013 Mar 28; 32(13):1691-701. PMID: 22665064.
      View in: PubMed
    96. Li JY, Lopez JI, Powell SZ, Coons SW, Fuller GN. Giant cell ependymoma-report of three cases and review of the literature. Int J Clin Exp Pathol. 2012; 5(5):458-62. PMID: 22808300.
      View in: PubMed
    97. Raghunathan A, Olar A, Vogel H, Parker JR, Coventry SC, Debski R, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Fuller GN. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol. 2012 Aug; 16(4):255-9. PMID: 22445362.
      View in: PubMed
    98. Kamal MM, Sathyan P, Singh SK, Zinn PO, Marisetty AL, Liang S, Gumin J, El-Mesallamy HO, Suki D, Colman H, Fuller GN, Lang FF, Majumder S. REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells. 2012 Mar; 30(3):405-14. PMID: 22228704.
      View in: PubMed
    99. Lee I, Fox PS, Ferguson SD, Bassett R, Kong LY, Schacherer CW, Gershenwald JE, Grimm EA, Fuller GN, Heimberger AB. The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival. Oncotarget. 2012 Mar; 3(3):336-44. PMID: 22488042.
      View in: PubMed
    100. Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M, Hess K, Fuller GN, Zhang W. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-?B network. Proc Natl Acad Sci U S A. 2012 Feb 28; 109(9):3475-80. PMID: 22345562.
      View in: PubMed
    101. Olar A, Raghunathan A, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Goodman JC, Fuller GN. Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol. 2012 Jun; 16(3):161-70. PMID: 22197544.
      View in: PubMed
    102. Jonasch E, McCutcheon IE, Waguespack SG, Wen S, Davis DW, Smith LA, Tannir NM, Gombos DS, Fuller GN, Matin SF. Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. Ann Oncol. 2011 Dec; 22(12):2661-6. PMID: 22105611.
      View in: PubMed
    103. Li JY, Langford LA, Adesina A, Bodhireddy SR, Wang M, Fuller GN. The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma. Brain Tumor Pathol. 2012 Jan; 29(1):68-72. PMID: 21892765.
      View in: PubMed
    104. Hatiboglu MA, Kong LY, Wei J, Wang Y, McEnery KA, Fuller GN, Qiao W, Davies MA, Priebe W, Heimberger AB. The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models. Int J Cancer. 2012 Jul 01; 131(1):8-17. PMID: 21792892.
      View in: PubMed
    105. Xu J, Sampath D, Lang FF, Prabhu S, Rao G, Fuller GN, Liu Y, Puduvalli VK. Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures. J Neurooncol. 2011 Nov; 105(2):241-51. PMID: 21598070.
      View in: PubMed
    106. Singh A, Rokes C, Gireud M, Fletcher S, Baumgartner J, Fuller G, Stewart J, Zage P, Gopalakrishnan V. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(ß-TRCP) in neuroblastoma cells. Cancer. 2011 Nov 15; 117(22):5189-202. PMID: 21523764.
      View in: PubMed
    107. Fuller G, Bouamra O, Woodford M, Jenks T, Patel H, Coats TJ, Oakley P, Mendelow AD, Pigott T, Hutchinson PJ, Lecky F. Temporal trends in head injury outcomes from 2003 to 2009 in England and Wales. Br J Neurosurg. 2011 Jun; 25(3):414-21. PMID: 21513451.
      View in: PubMed
    108. Agnihotri S, Wolf A, Munoz DM, Smith CJ, Gajadhar A, Restrepo A, Clarke ID, Fuller GN, Kesari S, Dirks PB, McGlade CJ, Stanford WL, Aldape K, Mischel PS, Hawkins C, Guha A. A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med. 2011 Apr 11; 208(4):689-702. PMID: 21464220.
      View in: PubMed
    109. Cogdell D, Chung W, Liu Y, McDonald JM, Aldape K, Issa JP, Fuller GN, Zhang W. Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma. Chin J Cancer. 2011 Apr; 30(4):247-53. PMID: 21439246.
      View in: PubMed
    110. Doucette T, Yang Y, Zhang W, Fuller GN, Suki D, Fults DW, Rao G. Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma. Int J Cancer. 2011 Nov 01; 129(9):2093-103. PMID: 21171016.
      View in: PubMed
    111. Moore LM, Holmes KM, Fuller GN, Zhang W. Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model. Chin J Cancer. 2011 Mar; 30(3):163-72. PMID: 21352693.
      View in: PubMed
    112. Liu Y, Lang F, Xie X, Prabhu S, Xu J, Sampath D, Aldape K, Fuller G, Puduvalli VK. Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenografts. Cell Death Dis. 2011 Feb 24; 2:e121. PMID: 21368892.
      View in: PubMed
    113. Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol. 2011 Feb; 196(2):W187-93. PMID: 21257861.
      View in: PubMed
    114. Wei J, Wu A, Kong LY, Wang Y, Fuller G, Fokt I, Melillo G, Priebe W, Heimberger AB. Hypoxia potentiates glioma-mediated immunosuppression. PLoS One. 2011 Jan 20; 6(1):e16195. PMID: 21283755.
      View in: PubMed
    115. Staquicini FI, Ozawa MG, Moya CA, Driessen WH, Barbu EM, Nishimori H, Soghomonyan S, Flores LG, Liang X, Paolillo V, Alauddin MM, Basilion JP, Furnari FB, Bogler O, Lang FF, Aldape KD, Fuller GN, Höök M, Gelovani JG, Sidman RL, Cavenee WK, Pasqualini R, Arap W. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011 Jan; 121(1):161-73. PMID: 21183793.
      View in: PubMed
    116. Bell D, Gidley P, Levine N, Fuller GN. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience. Ann Diagn Pathol. 2011 Apr; 15(2):117-23. PMID: 21167761.
      View in: PubMed
    117. Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger AB. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses. Clin Cancer Res. 2010 Dec 01; 16(23):5722-33. PMID: 20921210.
      View in: PubMed
    118. Gopalakrishnan V, Bie B, Sinnappah-Kang ND, Adams H, Fuller GN, Pan ZZ, Majumder S. Myoblast-derived neuronal cells form glutamatergic neurons in the mouse cerebellum. Stem Cells. 2010 Oct; 28(10):1839-47. PMID: 20799335.
      View in: PubMed
    119. Mendes KN, Wang GK, Fuller GN, Zhang W. JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration. Int J Oncol. 2010 Jul; 37(1):143-53. PMID: 20514406.
      View in: PubMed
    120. Kumar AJ, Leeds NE, Kumar VA, Fuller GN, Lang FF, Milas Z, Weinberg JS, Ater JL, Sawaya R. Magnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high-grade gliomas. J Comput Assist Tomogr. 2010 Jul; 34(4):601-11. PMID: 20657231.
      View in: PubMed
    121. Perry A, Burton SS, Fuller GN, Robinson CA, Palmer CA, Resch L, Bigio EH, Gujrati M, Rosenblum MK. Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall. Acta Neuropathol. 2010 Aug; 120(2):237-52. PMID: 20464403.
      View in: PubMed
    122. Rao P, Fuller GN, Prieto VG. Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall. Am J Dermatopathol. 2010 May; 32(3):262-6. PMID: 20098296.
      View in: PubMed
    123. Hassaneen W, Suki D, Salaskar AL, Wildrick DM, Lang FF, Fuller GN, Sawaya R. Surgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience. J Neurosurg. 2010 May; 112(5):1046-55. PMID: 19663549.
      View in: PubMed
    124. Ji P, Smith SM, Wang Y, Jiang R, Song SW, Li B, Sawaya R, Bruner JM, Kuang J, Yu H, Fuller GN, Zhang W. Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP. Oncogene. 2010 Jun 17; 29(24):3501-8. PMID: 20418911.
      View in: PubMed
    125. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Clin Cancer Res. 2010 May 01; 16(9):2550-61. PMID: 20388845.
      View in: PubMed
    126. de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, Conrad CA. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol. 2010 Mar; 12(3):233-42. PMID: 20167811.
      View in: PubMed
    127. Wu Y, Song SW, Sun J, Bruner JM, Fuller GN, Zhang W. IIp45 inhibits cell migration through inhibition of HDAC6. J Biol Chem. 2010 Feb 05; 285(6):3554-60. PMID: 20008322.
      View in: PubMed
    128. Higgins RJ, Dickinson PJ, LeCouteur RA, Bollen AW, Wang H, Wang H, Corely LJ, Moore LM, Zang W, Fuller GN. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol. 2010 May; 98(1):49-55. PMID: 19967449.
      View in: PubMed
    129. Gasco J, Franklin B, Fuller GN, Salinas P, Prabhu S. Multifocal epithelioid glioblastoma mimicking cerebral metastasis: case report. Neurocirugia (Astur). 2009 Dec; 20(6):550-4. PMID: 19967320.
      View in: PubMed
    130. Humphries W, Wang Y, Qiao W, Reina-Ortiz C, Abou-Ghazal MK, Crutcher LM, Wei J, Kong LY, Sawaya R, Rao G, Weinberg J, Prabhu SS, Fuller GN, Heimberger AB. yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients. J Transl Med. 2009 Nov 09; 7:92. PMID: 19900287.
      View in: PubMed
    131. Hassaneen W, Cahill DP, Fuller GN, Levine NB. Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma. J Neurooncol. 2010 May; 98(1):151-2. PMID: 19894022.
      View in: PubMed
    132. Alexander T, Fuller G, Hargovan P, Clarke DL, Muckart DJ, Thomson SR. An audit of the quality of care of traumatic brain injury at a busy regional hospital in South Africa. S Afr J Surg. 2009 Nov; 47(4):120-2, 124-6. PMID: 20141069.
      View in: PubMed
    133. Dhillon J, Krishnamurthy S, Fuller GN. Papillary tumour of the pineal region: diagnosis by cytology smear. Cytopathology. 2010 Aug; 21(4):267-9. PMID: 19832879.
      View in: PubMed
    134. Rokes C, Ketonen LM, Fuller GN, Weinberg J, Slopis JM, Wolff JE. Imaging and spectroscopic findings in meningioangiomatosis. Pediatr Blood Cancer. 2009 Oct; 53(4):672-4. PMID: 19544396.
      View in: PubMed
    135. Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, Sawaya R, Bruner JM, Fuller GN, Zhang W. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proc Natl Acad Sci U S A. 2009 Sep 29; 106(39):16675-9. PMID: 19805356.
      View in: PubMed
    136. Rodney AJ, Gombos DS, Fuller GN, Pagliaro LC, Tannir NM. Choroidal and conjunctival metastases from renal cell carcinoma. Am J Clin Oncol. 2009 Aug; 32(4):448-9. PMID: 19657240.
      View in: PubMed
    137. Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, Tucker SL, Buchholz TA. Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol. 2009 May; 33(5):759-67. PMID: 19252432.
      View in: PubMed
    138. Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan V. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL. J Neurooncol. 2009 Jul; 93(3):303-18. PMID: 19148581.
      View in: PubMed
    139. Heimberger AB, Kong LY, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Wei J, Qiao W, Schmittling RJ, Archer GE, Sampson JH, Hiraoka N, Priebe W, Fuller GN, Sawaya R. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clin Neurosurg. 2009; 56:98-106. PMID: 20214040.
      View in: PubMed
    140. Thomas RH, Higgins S, Fuller GN. Dental injury during seizures associated with juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry. 2009 Jan; 80(1):91-3. PMID: 19091715.
      View in: PubMed
    141. Vann VR, Giuliari GP, Banda RM, Chévez-Barrios P, Fuller GN, Gombos DS. Choroidal melanoma masquerading as panuveitis in a patient with multiple myeloma. Retin Cases Brief Rep. 2009; 3(2):152-5. PMID: 25391061.
      View in: PubMed
    142. Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA, Frost JA. Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):80-6. PMID: 19124484.
      View in: PubMed
    143. Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N, Priebe W, Sawaya R, Heimberger AB. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res. 2008 Dec 15; 14(24):8228-35. PMID: 19088040.
      View in: PubMed
    144. Kuo SH, Debnam JM, Fuller GN, de Groot J. Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients. Oncology. 2009; 76(1):10-8. PMID: 19018150.
      View in: PubMed
    145. Kong LY, Abou-Ghazal MK, Wei J, Chakraborty A, Sun W, Qiao W, Fuller GN, Fokt I, Grimm EA, Schmittling RJ, Archer GE, Sampson JH, Priebe W, Heimberger AB. A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells. Clin Cancer Res. 2008 Sep 15; 14(18):5759-68. PMID: 18794085.
      View in: PubMed
    146. Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Sun W, Qiao W, Hiraoka N, Fuller GN. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin Cancer Res. 2008 Aug 15; 14(16):5166-72. PMID: 18698034.
      View in: PubMed
    147. Amini E, Roffidal T, Lee A, Fuller GN, Mahajan A, Ketonen L, Kobrinsky N, Cairo MS, Wells RJ, Wolff JE. Central neurocytoma responsive to topotecan, ifosfamide, carboplatin. Pediatr Blood Cancer. 2008 Jul; 51(1):137-40. PMID: 18338396.
      View in: PubMed
    148. Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol. 2008 Jul; 18(3):307-16. PMID: 18532929.
      View in: PubMed
    149. Raslan O, Ketonen LM, Fuller GN, Schellingerhout D. Intracranial Rosai-Dorfman disease with relapsing spinal lesions. J Clin Oncol. 2008 Jun 20; 26(18):3087-9. PMID: 18565897.
      View in: PubMed
    150. Fuller GN. The WHO Classification of Tumours of the Central Nervous System, 4th edition. Arch Pathol Lab Med. 2008 Jun; 132(6):906. PMID: 18517270.
      View in: PubMed
    151. de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK. Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol. 2008 Jun; 88(2):121-33. PMID: 18317690.
      View in: PubMed
    152. Masoudi A, Amini E, Wolff JE, Fuller GN, Ketonen L, Mahajan A. Shrinkage of germinoma by dexamethasone only. Pediatr Blood Cancer. 2008 May; 50(5):1079. PMID: 18000859.
      View in: PubMed
    153. Wang H, Arun BK, Wang H, Fuller GN, Zhang W, Middleton LP, Sahin AA. IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas. Breast J. 2008 May-Jun; 14(3):261-7. PMID: 18373644.
      View in: PubMed
    154. Li JY, Wang H, May S, Song X, Fueyo J, Fuller GN, Wang H. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas. J Neurooncol. 2008 May; 88(1):11-7. PMID: 18246408.
      View in: PubMed
    155. Yoo JH, Rivera A, Naeini RM, Yedururi S, Bayindir P, Megahead H, Fuller GN, Suh JS, Adesina AM, Hunter JV. Melanotic paraganglioma arising in the temporal horn following Langerhans cell histiocytosis. Pediatr Radiol. 2008 May; 38(5):571-4. PMID: 18196230.
      View in: PubMed
    156. Liang JJ, Alrawi S, Fuller GN, Tan D. Carcinoid tumors arising in tailgut cysts may be associated with estrogen receptor status: case report and review of the literature. Int J Clin Exp Pathol. 2008 Jan 01; 1(6):539-43. PMID: 18787681.
      View in: PubMed
    157. Chang AH, Fuller GN, Debnam JM, Karis JP, Coons SW, Ross JS, Dean BL. MR imaging of papillary tumor of the pineal region. AJNR Am J Neuroradiol. 2008 Jan; 29(1):187-9. PMID: 17925365.
      View in: PubMed
    158. Hirst CL, Fuller GN, Lammie GA, Hughes TA. Clear cell carcinoma of the kidney in a young man with neurological complications. Pract Neurol. 2007 Oct; 7(5):306-14. PMID: 17885269.
      View in: PubMed
    159. Williams MD, Asa SL, Fuller GN. Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol. 2008 Jun; 12(3):199-203. PMID: 18486896.
      View in: PubMed
    160. McCutcheon IE, Waguespack SG, Fuller GN, Couldwell WT. Metastatic melanoma to the pituitary gland. Can J Neurol Sci. 2007 Aug; 34(3):322-7. PMID: 17803030.
      View in: PubMed
    161. Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, Zhang W. Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci U S A. 2007 Jul 10; 104(28):11736-41. PMID: 17606927.
      View in: PubMed
    162. Brat DJ, Scheithauer BW, Fuller GN, Tihan T. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol. 2007 Jul; 17(3):319-24. PMID: 17598825.
      View in: PubMed
    163. Zhang W, Fuller G. IGFBP2 as a brain tumor oncogene. Cancer Biol Ther. 2007 Jul; 6(7):995-6. PMID: 19358341.
      View in: PubMed
    164. Fuller GN, Scheithauer BW. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 2007 Jul; 17(3):304-7. PMID: 17598822.
      View in: PubMed
    165. Barnett JA, Urbauer DL, Murray GI, Fuller GN, Heimberger AB. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res. 2007 Jun 15; 13(12):3559-67. PMID: 17575219.
      View in: PubMed
    166. Olson MV, Johnson DG, Jiang H, Xu J, Alonso MM, Aldape KD, Fuller GN, Bekele BN, Yung WK, Gomez-Manzano C, Fueyo J. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9. PMID: 17483310.
      View in: PubMed
    167. Lee OH, Xu J, Fueyo J, Fuller GN, Aldape KD, Alonso MM, Piao Y, Liu TJ, Lang FF, Bekele BN, Gomez-Manzano C. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res. 2006 Dec; 4(12):915-26. PMID: 17189382.
      View in: PubMed
    168. Houshmandi SS, Surace EI, Zhang HB, Fuller GN, Gutmann DH. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor. Neurology. 2006 Nov 28; 67(10):1863-6. PMID: 17130425.
      View in: PubMed
    169. Fuller GN. Narrowing the differential diagnosis in surgical neuropathology. Arch Pathol Lab Med. 2006 Nov; 130(11):1602. PMID: 17076519.
      View in: PubMed
    170. Xu JJ, Walla BC, Diaz MF, Fuller GN, Gutstein HB. Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance. Anesth Analg. 2006 Sep; 103(3):714-20. PMID: 16931686.
      View in: PubMed
    171. Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, Fuller GN, Aldape KD. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res. 2006 Jul 01; 12(13):3935-41. PMID: 16818690.
      View in: PubMed
    172. Wang H, Wang H, Zhang W, Fuller GN. Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat. 2006 Jun; 5(3):195-9. PMID: 16700616.
      View in: PubMed
    173. Cheung HC, Corley LJ, Fuller GN, McCutcheon IE, Cote GJ. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol. 2006 Aug; 19(8):1034-41. PMID: 16729017.
      View in: PubMed
    174. Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu J. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006 Sep; 19(9):1149-56. PMID: 16729015.
      View in: PubMed
    175. Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, Tabus I, Aldape K, Sawaya R, Bruner JM, Fuller GN, Zhang W. Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics. 2006 May; 6(10):2964-71. PMID: 16619307.
      View in: PubMed
    176. Lee OH, Fueyo J, Xu J, Yung WK, Lemoine MG, Lang FF, Bekele BN, Zhou X, Alonso MA, Aldape KD, Fuller GN, Gomez-Manzano C. Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia. 2006 May; 8(5):419-28. PMID: 16790091.
      View in: PubMed
    177. Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol. 2006 May; 30(5):657-64. PMID: 16699322.
      View in: PubMed
    178. Levin VA, Phuphanich S, Yung WK, Forsyth PA, Maestro RD, Perry JR, Fuller GN, Baillet M. Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. J Neurooncol. 2006 Jul; 78(3):295-302. PMID: 16636750.
      View in: PubMed
    179. Leeds NE, Lang FF, Ribalta T, Sawaya R, Fuller GN. Origin of chordoid glioma of the third ventricle. Arch Pathol Lab Med. 2006 Apr; 130(4):460-4. PMID: 16594739.
      View in: PubMed
    180. Wang L, Wei Q, Wang LE, Aldape KD, Cao Y, Okcu MF, Hess KR, El-Zein R, Gilbert MR, Woo SY, Prabhu SS, Fuller GN, Bondy ML. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol. 2006 Apr 01; 24(10):1627-32. PMID: 16575014.
      View in: PubMed
    181. Wang GK, Hu L, Fuller GN, Zhang W. An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem. 2006 May 19; 281(20):14085-91. PMID: 16569642.
      View in: PubMed
    182. McDonald JM, Dunlap S, Cogdell D, Dunmire V, Wei Q, Starzinski-Powitz A, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang W. The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration. Cancer Biol Ther. 2006 Mar; 5(3):300-4. PMID: 16410724.
      View in: PubMed
    183. Huo L, Moran CA, Fuller GN, Gladish G, Suster S. Pulmonary artery sarcoma: a clinicopathologic and immunohistochemical study of 12 cases. Am J Clin Pathol. 2006 Mar; 125(3):419-24. PMID: 16613346.
      View in: PubMed
    184. Su X, Gopalakrishnan V, Stearns D, Aldape K, Lang FF, Fuller G, Snyder E, Eberhart CG, Majumder S. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol Cell Biol. 2006 Mar; 26(5):1666-78. PMID: 16478988.
      View in: PubMed
    185. Costelloe CM, Fuller GN, Kumar AJ, Cline K, Neitzschman HR. Radiology case of the month. Palmar mass and finger weakness. Fibrolipomatous hamartoma. J La State Med Soc. 2006 Jan-Feb; 158(1):7-8. PMID: 16602477.
      View in: PubMed
    186. Patel AJ, Fuller GN, Wildrick DM, Sawaya R. Pineal cyst apoplexy: case report and review of the literature. Neurosurgery. 2005 Nov; 57(5):E1066; discussion E1066. PMID: 16284546.
      View in: PubMed
    187. McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer. 2005 Oct 01; 104(7):1468-77. PMID: 16088966.
      View in: PubMed
    188. McDonald JM, Dunmire V, Taylor E, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang W. Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss. Mol Cancer. 2005 Sep 12; 4:35. PMID: 16156899.
      View in: PubMed
    189. Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang W. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression. Oncol Rep. 2005 Sep; 14(3):651-6. PMID: 16077969.
      View in: PubMed
    190. Chen LL, Sabripour M, Wu EF, Prieto VG, Fuller GN, Frazier ML. A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene. 2005 Jun 16; 24(26):4271-80. PMID: 15824741.
      View in: PubMed
    191. Spencer ML, Neto AG, Fuller GN, Luna MA. Intracranial extension of acinic cell carcinoma of the parotid gland. Arch Pathol Lab Med. 2005 Jun; 129(6):780-2. PMID: 15913428.
      View in: PubMed
    192. Fuller G, O'Beirne M, Murphy P, Oware A. "EEG happy families": the fun way to learn about common EEG abnormalities. J Neurol Neurosurg Psychiatry. 2005 Jun; 76 Suppl 2:ii13-5, ii46. PMID: 15961862.
      View in: PubMed
    193. Song SW, Fuller GN, Zheng H, Zhang W. Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas. Cancer Res. 2005 May 01; 65(9):3562-7. PMID: 15867349.
      View in: PubMed
    194. Dai C, Lyustikman Y, Shih A, Hu X, Fuller GN, Rosenblum M, Holland EC. The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats. Neoplasia. 2005 Apr; 7(4):397-406. PMID: 15967117.
      View in: PubMed
    195. Kim JH, Tuziak T, Hu L, Wang Z, Bondaruk J, Kim M, Fuller G, Dinney C, Grossman HB, Baggerly K, Zhang W, Czerniak B. Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Lab Invest. 2005 Apr; 85(4):532-49. PMID: 15778693.
      View in: PubMed
    196. Fuller GN, Su X, Price RE, Cohen ZR, Lang FF, Sawaya R, Majumder S. Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Mol Cancer Ther. 2005 Mar; 4(3):343-9. PMID: 15767543.
      View in: PubMed
    197. de Groot JF, Liu TJ, Fuller G, Yung WK. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 2005 Mar 01; 65(5):1934-40. PMID: 15753393.
      View in: PubMed
    198. Neto AG, McCutcheon IE, Vang R, Spencer ML, Zhang W, Fuller GN. Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomas. Ann Diagn Pathol. 2005 Feb; 9(1):6-10. PMID: 15692944.
      View in: PubMed
    199. Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res. 2005 Jan 01; 11(1):267-72. PMID: 15671555.
      View in: PubMed
    200. Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004 Nov; 28(11):1532-6. PMID: 15489659.
      View in: PubMed
    201. Saadati H, Calvano C, Diba R, Fuller GN, Gombos D, De Monte F, Urso R, Esmaeli B. Orbital and optic chiasmal extension of uveal melanoma. Ophthalmic Plast Reconstr Surg. 2004 Sep; 20(5):387-90. PMID: 15377909.
      View in: PubMed
    202. Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004 Sep 01; 64(17):5913-9. PMID: 15342366.
      View in: PubMed
    203. Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN. Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest. 2004 Aug; 84(8):941-51. PMID: 15184909.
      View in: PubMed
    204. Ribalta T, McCutcheon IE, Neto AG, Gupta D, Kumar AJ, Biddle DA, Langford LA, Bruner JM, Leeds NE, Fuller GN. Textiloma (gossypiboma) mimicking recurrent intracranial tumor. Arch Pathol Lab Med. 2004 Jul; 128(7):749-58. PMID: 15214828.
      View in: PubMed
    205. Lassman AB, Dai C, Fuller GN, Vickers AJ, Holland EC. Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biol. 2004 May; 1(2):157-63. PMID: 17047730.
      View in: PubMed
    206. Hao X, Sun B, Hu L, Lähdesmäki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang W. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004 Mar 15; 100(6):1110-22. PMID: 15022276.
      View in: PubMed
    207. Raza SM, Fuller GN, Rhee CH, Huang S, Hess K, Zhang W, Sawaya R. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):212-21. PMID: 14734472.
      View in: PubMed
    208. McCutcheon IE, Hentschel SJ, Fuller GN, Jin W, Cote GJ. Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain. Neuro Oncol. 2004 Jan; 6(1):9-14. PMID: 14769134.
      View in: PubMed
    209. Maldaun MV, Suki D, Lang FF, Prabhu S, Shi W, Fuller GN, Wildrick DM, Sawaya R. Cystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg. 2004 Jan; 100(1):61-7. PMID: 14743913.
      View in: PubMed
    210. Vogel H, Fuller GN. Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems. Ann Diagn Pathol. 2003 Dec; 7(6):387-98. PMID: 15018124.
      View in: PubMed
    211. Song SW, Fuller GN, Khan A, Kong S, Shen W, Taylor E, Ramdas L, Lang FF, Zhang W. IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):13970-5. PMID: 14617774.
      View in: PubMed
    212. Wang H, Shen SS, Wang H, Diwan AH, Zhang W, Fuller GN, Prieto VG. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol. 2003 Nov; 30(10):599-605. PMID: 14744083.
      View in: PubMed
    213. Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DP. Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg. 2003 Oct; 99(4):693-700. PMID: 14567605.
      View in: PubMed
    214. Baumgartner JE, Ater JL, Ha CS, Kuttesch JF, Leeds NE, Fuller GN, Wilson RJ. Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors. Pediatr Neurosurg. 2003 Oct; 39(4):201-7. PMID: 12944701.
      View in: PubMed
    215. Hong DS, Jacobson KL, Raad II, de Lima M, Anderlini P, Fuller GN, Ippoliti C, Cool RM, Leeds NE, Narvios A, Han XY, Padula A, Champlin RE, Hosing C. West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis. 2003 Oct 15; 37(8):1044-9. PMID: 14523768.
      View in: PubMed
    216. Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang W. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003 Aug 01; 63(15):4315-21. PMID: 12907597.
      View in: PubMed
    217. Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH. Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Jul 15; 56(4):1137-46. PMID: 12829152.
      View in: PubMed
    218. Lee HK, Chang EL, Fuller GN, Aldape KD, Atkinson GJ, Levy LB, McCutcheon IE, Maor MH. The prognostic value of neurologic function in astrocytic spinal cord glioma. Neuro Oncol. 2003 07; 5(3):208-13. PMID: 12816727.
      View in: PubMed
    219. Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003 Jul 01; 21(13):2508-18. PMID: 12839017.
      View in: PubMed
    220. Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60. PMID: 12734316.
      View in: PubMed
    221. Brown HM, McCutcheon IE, Leeds NE, Schomer DS, Luna MA, Fuller GN. Melanoma metastatic to central neurocytoma: a novel case of tumor-to-tumor metastasis. J Neurooncol. 2003 Feb; 61(3):209-14. PMID: 12675313.
      View in: PubMed
    222. Tran TA, Fuller GN, Whitman GJ, Schomer DF. Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Delayed cerebral radiation necrosis. AJR Am J Roentgenol. 2003 Jan; 180(1):70. PMID: 12490478.
      View in: PubMed
    223. Bataller L, Wade DF, Fuller GN, Rosenfeld MR, Dalmau J. Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum. Neurology. 2002 Dec 24; 59(12):1985-7. PMID: 12499499.
      View in: PubMed
    224. Fuller CE, Wang H, Zhang W, Fuller GN, Perry A. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol. 2002 Dec; 61(12):1078-84. PMID: 12484570.
      View in: PubMed
    225. Shukla V, Hayman LA, Ly C, Fuller G, Taber KH. Adult cranial dura I: intrinsic vessels. J Comput Assist Tomogr. 2002 Nov-Dec; 26(6):1069-74. PMID: 12488763.
      View in: PubMed
    226. Kim S, Dougherty ER, Shmulevich I, Hess KR, Hamilton SR, Trent JM, Fuller GN, Zhang W. Identification of combination gene sets for glioma classification. Mol Cancer Ther. 2002 Nov; 1(13):1229-36. PMID: 12479704.
      View in: PubMed
    227. Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN, Holland EC. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res. 2002 Oct 01; 62(19):5551-8. PMID: 12359767.
      View in: PubMed
    228. Erana-Rojas IE, Barboza-Quintana A, Ayala AG, Fuller GN. Demyelinating pseudotumor. Ann Diagn Pathol. 2002 Oct; 6(5):265-71. PMID: 12376918.
      View in: PubMed
    229. Lang FF, Gilbert MR, Puduvalli VK, Weinberg J, Levin VA, Yung WK, Sawaya R, Fuller GN, Conrad CA. Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies. Neuro Oncol. 2002 10; 4(4):268-77. PMID: 12356357.
      View in: PubMed
    230. Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery. 2002 Jul; 51(1):2-12; discussion 12-3. PMID: 12182418.
      View in: PubMed
    231. Tremont-Lukats IW, Fuller GN, Ribalta T, Giglio P, Groves MD. Paraneoplastic chorea: case study with autopsy confirmation. Neuro Oncol. 2002 07; 4(3):192-5. PMID: 12084350.
      View in: PubMed
    232. Hu L, Wang J, Baggerly K, Wang H, Fuller GN, Hamilton SR, Coombes KR, Zhang W. Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics. 2002 Jun 21; 3:16. PMID: 12086591.
      View in: PubMed
    233. Marmor E, Fourney DR, Rhines LD, Skibber JM, Fuller GN, Gokaslan ZL. Sacrococcygeal ganglioneuroma. J Spinal Disord Tech. 2002 Jun; 15(3):265-8. PMID: 12131432.
      View in: PubMed
    234. Cohen ZR, Marmor E, Fuller GN, DeMonte F. Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus. 2002 May 15; 12(5):e3. PMID: 16119901.
      View in: PubMed
    235. Schaefer LK, Ren Z, Fuller GN, Schaefer TS. Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene. 2002 Mar 27; 21(13):2058-65. PMID: 11960378.
      View in: PubMed
    236. Adachi Y, Chandrasekar N, Kin Y, Lakka SS, Mohanam S, Yanamandra N, Mohan PM, Fuller GN, Fang B, Fueyo J, Dinh DH, Olivero WC, Tamiya T, Ohmoto T, Kyritsis AP, Rao JS. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene. 2002 Jan 03; 21(1):87-95. PMID: 11791179.
      View in: PubMed
    237. Zhang W, Wang H, Song SW, Fuller GN. Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm. Brain Pathol. 2002 Jan; 12(1):87-94. PMID: 11770904.
      View in: PubMed
    238. Begemann M, Fuller GN, Holland EC. Genetic modeling of glioma formation in mice. Brain Pathol. 2002 Jan; 12(1):117-32. PMID: 11770894.
      View in: PubMed
    239. Wang H, Wang H, Zhang W, Fuller GN. Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol. 2002 Jan; 12(1):95-107. PMID: 11770905.
      View in: PubMed
    240. Fuller GN, Hess KR, Rhee CH, Yung WK, Sawaya RA, Bruner JM, Zhang W. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol. 2002 Jan; 12(1):108-16. PMID: 11771519.
      View in: PubMed
    241. Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Kin Y, Fuller GN, Lakka SS, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Yung WK, Rao JS. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clin Cancer Res. 2001 Aug; 7(8):2519-26. PMID: 11489835.
      View in: PubMed
    242. Hess KR, Fuller GN, Rhee CH, Zhang W. Statistical pattern analysis of gene expression profiles for glioblastoma tissues and cell lines. Int J Mol Med. 2001 Aug; 8(2):183-8. PMID: 11445872.
      View in: PubMed
    243. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001 Aug 01; 15(15):1913-25. PMID: 11485986.
      View in: PubMed
    244. Vang R, Medeiros LJ, Fuller GN, Sarris AH, Deavers M. Non-Hodgkin's lymphoma involving the gynecologic tract: a review of 88 cases. Adv Anat Pathol. 2001 Jul; 8(4):200-17. PMID: 11444509.
      View in: PubMed
    245. Jackson RJ, Fuller GN, Abi-Said D, Lang FF, Gokaslan ZL, Shi WM, Wildrick DM, Sawaya R. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 2001 07; 3(3):193-200. PMID: 11465400.
      View in: PubMed
    246. Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Lakka SS, Kin Y, Fuller GN, Yung AW, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Rao JS. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene. 2001 Jun 21; 20(28):3665-73. PMID: 11439329.
      View in: PubMed
    247. Hanbali F, Fuller GN, Leeds NE, Sawaya R. Choroid plexus cyst and chordoid glioma. Report of two cases. Neurosurg Focus. 2001 Jun 15; 10(6):E5. PMID: 16724823.
      View in: PubMed
    248. Fuller G, Veitch K, Ho LK, Cruise L, Morris BJ. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase. Brain Res Mol Brain Res. 2001 Apr 18; 89(1-2):126-32. PMID: 11311983.
      View in: PubMed
    249. Rao CN, Lakka SS, Kin Y, Konduri SD, Fuller GN, Mohanam S, Rao JS. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clin Cancer Res. 2001 Mar; 7(3):570-6. PMID: 11297250.
      View in: PubMed
    250. Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, Nirmala C, Lakka SS, Adachi Y, Kyritsis AP, Ali-Osman F, Sawaya R, Fuller GN, Rao JS. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res. 2000 Dec 15; 60(24):6851-5. PMID: 11156378.
      View in: PubMed
    251. Lang FF, Macdonald OK, Fuller GN, DeMonte F. Primary extradural meningiomas: a report on nine cases and review of the literature from the era of computerized tomography scanning. J Neurosurg. 2000 Dec; 93(6):940-50. PMID: 11117866.
      View in: PubMed
    252. Puduvalli VK, Kyritsis AP, Hess KR, Bondy ML, Fuller GN, Kouraklis GP, Levin VA, Bruner JM. Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival. Int J Oncol. 2000 Nov; 17(5):963-9. PMID: 11029499.
      View in: PubMed
    253. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology. 2000 Nov; 217(2):377-84. PMID: 11058631.
      View in: PubMed
    254. Fourney DR, Fuller GN, Gokaslan ZL. Intraspinal extradural myxopapillary ependymoma of the sacrum arising from the filum terminale externa. Case report. J Neurosurg. 2000 Oct; 93(2 Suppl):322-6. PMID: 11012069.
      View in: PubMed
    255. Holland EC, Li Y, Celestino J, Dai C, Schaefer L, Sawaya RA, Fuller GN. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo. Am J Pathol. 2000 Sep; 157(3):1031-7. PMID: 10980141.
      View in: PubMed
    256. Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling. Histol Histopathol. 2000 07; 15(3):971-81. PMID: 10963139.
      View in: PubMed
    257. Lawinger P, Venugopal R, Guo ZS, Immaneni A, Sengupta D, Lu W, Rastelli L, Marin Dias Carneiro A, Levin V, Fuller GN, Echelard Y, Majumder S. The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells. Nat Med. 2000 Jul; 6(7):826-31. PMID: 10888935.
      View in: PubMed
    258. Verma KK, Forman AD, Fuller GN, Dimachkie MM, Vriesendorp FJ. Cauda equina syndrome as the isolated presentation of sarcoidosis. J Neurol. 2000 Jul; 247(7):573-4. PMID: 10993507.
      View in: PubMed
    259. Saad ED, Thomas DA, O'Brien S, Fuller GN, Medeiros LJ, Forman A, Albitar M, Schomer D, Kantarjian HM, Keating MJ. Progressive multifocal leukoencephalopathy with concurrent Richter's syndrome. Leuk Lymphoma. 2000 Jun; 38(1-2):183-90. PMID: 10811461.
      View in: PubMed
    260. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 2000 May; 25(1):55-7. PMID: 10802656.
      View in: PubMed
    261. McCutcheon IE, Pieper DR, Fuller GN, Benjamin RS, Friend KE, Gagel RF. Pituitary carcinoma containing gonadotropins: treatment by radical excision and cytotoxic chemotherapy: case report. Neurosurgery. 2000 May; 46(5):1233-9; discussion 1239-40. PMID: 10807257.
      View in: PubMed
    262. Jin W, McCutcheon IE, Fuller GN, Huang ES, Cote GJ. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res. 2000 Mar 01; 60(5):1221-4. PMID: 10728679.
      View in: PubMed
    263. Cruise L, Ho LK, Veitch K, Fuller G, Morris BJ. Kainate receptors activate NF-kappaB via MAP kinase in striatal neurones. Neuroreport. 2000 Feb 07; 11(2):395-8. PMID: 10674493.
      View in: PubMed
    264. Lal S, Lacroix M, Tofilon P, Fuller GN, Sawaya R, Lang FF. An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg. 2000 Feb; 92(2):326-33. PMID: 10659021.
      View in: PubMed
    265. McCutcheon IE, Friend KE, Gerdes TM, Zhang BM, Wildrick DM, Fuller GN. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth. J Neurosurg. 2000 Feb; 92(2):306-14. PMID: 10659019.
      View in: PubMed
    266. Vang R, Heck K, Fuller GN, Medeiros LJ. Granular cell tumor of intracranial meninges. Clin Neuropathol. 2000 Jan-Feb; 19(1):41-4. PMID: 10774952.
      View in: PubMed
    267. Goussia AC, Bruner JM, Kyritsis AP, Agnantis NJ, Fuller GN. Cytogenetic and molecular genetic abnormalities in primitive neuroectodermal tumors of the central nervous system. Anticancer Res. 2000 Jan-Feb; 20(1A):65-73. PMID: 10769636.
      View in: PubMed
    268. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res. 1999 Sep 01; 59(17):4228-32. PMID: 10485462.
      View in: PubMed
    269. Rhee CH, Hess K, Jabbur J, Ruiz M, Yang Y, Chen S, Chenchik A, Fuller GN, Zhang W. cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. Oncogene. 1999 Apr 29; 18(17):2711-7. PMID: 10348345.
      View in: PubMed
    270. Malicki DM, Suh YK, Fuller GN, Shin SS. Angiotropic (intravascular) large cell lymphoma of T-cell phenotype presenting as acute appendicitis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1999 Apr; 123(4):335-7. PMID: 10320147.
      View in: PubMed
    271. Rhee CH, Ruan S, Chen S, Chenchik A, Levin VA, Yung AW, Fuller GN, Zhang W. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling. Oncol Rep. 1999 Mar-Apr; 6(2):393-401. PMID: 10023010.
      View in: PubMed
    272. York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery. 1999 Jan; 44(1):74-9; discussion 79-80. PMID: 9894966.
      View in: PubMed
    273. York JE, Berk RH, Fuller GN, Rao JS, Abi-Said D, Wildrick DM, Gokaslan ZL. Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg. 1999 Jan; 90(1 Suppl):73-8. PMID: 10413129.
      View in: PubMed
    274. Gokaslan ZL, Chintala SK, York JE, Boyapati V, Jasti S, Sawaya R, Fuller G, Wildrick DM, Nicolson GL, Rao JS. Expression and localization of urokinase-type plasminogen activator in human spinal column tumors. Clin Exp Metastasis. 1998 Nov; 16(8):713-9. PMID: 10211984.
      View in: PubMed
    275. Gokaslan ZL, Chintala SK, York JE, Boyapati V, Jasti S, Sawaya R, Fuller G, Wildrick DM, Nicolson GL, Rao JS. Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors. Clin Exp Metastasis. 1998 Nov; 16(8):721-8. PMID: 10211985.
      View in: PubMed
    276. Hayman LA, Fuller GN, Cavazos JE, Pfleger MJ, Meyers CA, Jackson EF. The hippocampus: normal anatomy and pathology. AJR Am J Roentgenol. 1998 Oct; 171(4):1139-46. PMID: 9763010.
      View in: PubMed
    277. Ruan S, Fuller G, Levin V, Bruner JM, Zhang W. Detection of p21WAF1/Cip1 in brain metastases. J Neurooncol. 1998 May; 37(3):223-8. PMID: 9524080.
      View in: PubMed
    278. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol. 1998 Apr; 49(4):436-40. PMID: 9537664.
      View in: PubMed
    279. Zhu Z, McCutcheon IE, Lopes MB, Laws ER, Wagner VL, Bruner JM, Fuller GN, Langford LA, Ang LW, Friend KE. Sulfonylurea receptor mRNA expression in pituitary macroadenomas. Endocrine. 1998 Feb; 8(1):7-12. PMID: 9666339.
      View in: PubMed
    280. Przepiorka D, Jaeckle KA, Birdwell RR, Fuller GN, Kumar AJ, Huh YO, McCutcheon I. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant. 1997 Dec; 20(11):983-7. PMID: 9422479.
      View in: PubMed
    281. Broadley SA, Fuller GN. Lumbar puncture needn't be a headache. BMJ. 1997 Nov 22; 315(7119):1324-5. PMID: 9402759.
      View in: PubMed
    282. Eng DY, DeMonte F, Ginsberg L, Fuller GN, Jaeckle K. Craniospinal dissemination of central neurocytoma. Report of two cases. J Neurosurg. 1997 Mar; 86(3):547-52. PMID: 9046315.
      View in: PubMed
    283. Fuller GN, Kaba SE, Ginsberg LE, McCutcheon IE, Langford LA. Late sequelae of treated pleomorphic xanthoastrocytoma: malignant brain stem astrocytoma occurring 15 years after radiation therapy. J Neurooncol. 1997 Mar; 32(1):57-61. PMID: 9049863.
      View in: PubMed
    284. Bruner JM, Inouye L, Fuller GN, Langford LA. Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer. 1997 Feb 15; 79(4):796-803. PMID: 9024718.
      View in: PubMed
    285. Fuller GN, Batsakis JG. Pharyngeal hypophysis. Ann Otol Rhinol Laryngol. 1996 Aug; 105(8):671-2. PMID: 8712642.
      View in: PubMed
    286. Akeyson EW, McCutcheon IE, Pershouse MA, Steck PA, Fuller GN. Primitive neuroectodermal tumor of the median nerve. Case report with cytogenetic analysis. J Neurosurg. 1996 Jul; 85(1):163-9. PMID: 8683268.
      View in: PubMed
    287. Chintala SK, Sawaya R, Gokaslan ZL, Fuller G, Rao JS. Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro. Cancer Lett. 1996 Mar 19; 101(1):107-14. PMID: 8625273.
      View in: PubMed
    288. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 1996 Jan 15; 56(2):384-92. PMID: 8542596.
      View in: PubMed
    289. Sivaparvathi M, Yamamoto M, Nicolson GL, Gokaslan ZL, Fuller GN, Liotta LA, Sawaya R, Rao JS. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Clin Exp Metastasis. 1996 Jan; 14(1):27-34. PMID: 8521613.
      View in: PubMed
    290. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis. 1996 Jan; 14(1):35-42. PMID: 8521615.
      View in: PubMed
    291. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL, Sawaya RE. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis. 1996 Jan; 14(1):12-8. PMID: 8521611.
      View in: PubMed
    292. Hammoud MA, Hassenbusch SJ, Fuller GN, Shi W, Leeds NE. Multiple brain metastases: a rare manifestation of adenoid cystic carcinoma of the parotid gland. J Neurooncol. 1996 Jan; 27(1):61-4. PMID: 8699227.
      View in: PubMed
    293. Isiklar I, Leeds NE, Fuller GN, Kumar AJ. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. AJR Am J Roentgenol. 1995 Dec; 165(6):1503-12. PMID: 7484597.
      View in: PubMed
    294. Manford M, Fuller GN, Wade JP. "Silent diabetes": non-ketotic hyperglycaemia presenting as aphasic status epilepticus. J Neurol Neurosurg Psychiatry. 1995 Jul; 59(1):99-100. PMID: 7608722.
      View in: PubMed
    295. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem. 1995 May 12; 270(19):11463-71. PMID: 7744784.
      View in: PubMed
    296. Fuller GN, Matthews TD, Maini RN, Kennard C. An unusual cause for diplopia: acquired Brown's syndrome. J Neurol Neurosurg Psychiatry. 1995 Apr; 58(4):506-7. PMID: 7738569.
      View in: PubMed
    297. Fuller GN, Spies JM, Pollard JD, McLeod JG. Demyelinating neuropathies triggered by melanoma immunotherapy. Neurology. 1994 Dec; 44(12):2404-5. PMID: 7991137.
      View in: PubMed
    298. Goodrich-Tanrikulu M, Stafford AE, Lin JT, Makapugay MI, Fuller G, McKeon TA. Fatty acid biosynthesis in novel ufa mutants of Neurospora crassa. Microbiology. 1994 Oct; 140 ( Pt 10):2683-90. PMID: 8000539.
      View in: PubMed
    299. McKee P, Fuller GN, Stevens DL. Riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994 Jul 28; 331(4):272; author reply 273-4. PMID: 8068095.
      View in: PubMed
    300. Blunt SB, Fuller G, Kennard C, Brooks D. Orolingual dystonia with "tip of the tongue" geste. Mov Disord. 1994 Jul; 9(4):466. PMID: 7969217.
      View in: PubMed
    301. Fuller GN, Dick JP, Colquhoun IR. Brachial plexus compression by hematoma following jugular puncture. Neurology. 1994 Apr; 44(4):775-6. PMID: 8164848.
      View in: PubMed
    302. Boyko OB, Alston SR, Fuller GN, Hulette CM, Johnson GA, Burger PC. Utility of postmortem magnetic resonance imaging in clinical neuropathology. Arch Pathol Lab Med. 1994 Mar; 118(3):219-25. PMID: 8135623.
      View in: PubMed
    303. Nashold JR, Oakes WJ, Friedman HS, Halperin EC, Soo M, Hockenberger B, Fuller GN, Tien R. Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein. Med Pediatr Oncol. 1994; 22(2):137-9. PMID: 7505047.
      View in: PubMed
    304. Montine TJ, Fuller GN. Wernicke's encephalopathy in a patient with AIDS. AIDS. 1993 May; 7(5):744-5. PMID: 8318185.
      View in: PubMed
    305. Bruner JM, Langford LA, Fuller GN. Neuropathology, cell biology, and newer diagnostic methods. Curr Opin Oncol. 1993 May; 5(3):441-9. PMID: 8494905.
      View in: PubMed
    306. Fuller GN, Marshall A, Flint J, Lewis S, Wise RJ. Migraine madness: recurrent psychosis after migraine. J Neurol Neurosurg Psychiatry. 1993 Apr; 56(4):416-8. PMID: 8482964.
      View in: PubMed
    307. Ashdown BC, Boyko OB, Uglietta JP, Friedman HS, Hockenberger B, Oakes WJ, Fuller GN. Postradiation cerebellar necrosis mimicking tumor: MR appearance. J Comput Assist Tomogr. 1993 Jan-Feb; 17(1):124-6. PMID: 8419419.
      View in: PubMed
    308. Wikstrand CJ, Longee DC, McLendon RE, Fuller GN, Friedman HS, Fredman P, Svennerholm L, Bigner DD. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo. Cancer Res. 1993 Jan 01; 53(1):120-6. PMID: 8416736.
      View in: PubMed
    309. Bruggers CS, Friedman HS, Fuller GN, Tien RD, Marks LB, Halperin EC, Hockenberger B, Oakes WJ, Hoffman JM. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. Med Pediatr Oncol. 1993; 21(4):301-6. PMID: 8469227.
      View in: PubMed
    310. Lueder GT. Successful therapy for trilateral retinoblastoma. Am J Ophthalmol. 1992 Nov 15; 114(5):646-7. PMID: 1443038.
      View in: PubMed
    311. Abramson DH. Successful therapy for trilateral retinoblastoma. Am J Ophthalmol. 1992 Nov 15; 114(5):647-8. PMID: 1443039.
      View in: PubMed
    312. Rippe DJ, Boyko OB, Radi M, Worth R, Fuller GN. MRI of temporal lobe pleomorphic xanthoastrocytoma. J Comput Assist Tomogr. 1992 Nov-Dec; 16(6):856-9. PMID: 1385498.
      View in: PubMed
    313. Fuller GN, Jacobs JM, Lewis PD, Lane RJ. Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement. J Neurol Neurosurg Psychiatry. 1992 Nov; 55(11):1079-83. PMID: 1469406.
      View in: PubMed
    314. Malik RK, Fuller GN, Oakes WJ, Tien R, Hockenberger B, Friedman HS, Halperin EC. Back pain and paraplegia in a fifteen-year-old boy. J Pediatr. 1992 Oct; 121(4):652-8. PMID: 1403406.
      View in: PubMed
    315. Nelson SC, Friedman HS, Oakes WJ, Halperin EC, Tien R, Fuller GN, Hockenberger B, Scroggs MW, Moncino M, Kurtzberg J, et al. Successful therapy for trilateral retinoblastoma. Am J Ophthalmol. 1992 Jul 15; 114(1):23-9. PMID: 1621782.
      View in: PubMed
    316. Rasheed BK, Fuller GN, Friedman AH, Bigner DD, Bigner SH. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer. 1992 Jul; 5(1):75-82. PMID: 1384665.
      View in: PubMed
    317. Fuller GN, Bigner SH. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res. 1992 May; 276(3):299-306. PMID: 1374522.
      View in: PubMed
    318. Fuller GN. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr. 1992; 5 Suppl 1:S33-6. PMID: 1318366.
      View in: PubMed
    319. Wikstrand CJ, He XM, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD. Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo. J Neuropathol Exp Neurol. 1991 Nov; 50(6):756-69. PMID: 1748882.
      View in: PubMed
    320. Grevelink SA, Fuller GN, Olsen EA. Central nervous system involvement by cutaneous T cell lymphoma. J Am Acad Dermatol. 1991 Sep; 25(3):542-9. PMID: 1918492.
      View in: PubMed
    321. Burger PC, Fuller GN. Pathology--trends and pitfalls in histologic diagnosis, immunopathology, and applications of oncogene research. Neurol Clin. 1991 May; 9(2):249-71. PMID: 1682793.
      View in: PubMed
    322. Longee DC, Wikstrand CJ, Månsson JE, He X, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas. Acta Neuropathol. 1991; 82(1):45-54. PMID: 1659106.
      View in: PubMed
    323. Longee DC, Friedman HS, Phillips PC, Burger PC, Oakes WJ, Heffez D, Wharam M, Strauss L, Fuller GN, Schold SC. Osteoblastic metastases from astrocytomas: a report of two cases. Med Pediatr Oncol. 1991; 19(4):318-24. PMID: 2056977.
      View in: PubMed
    324. Fuller GN, Burger PC. Nervus terminalis (cranial nerve zero) in the adult human. Clin Neuropathol. 1990 Nov-Dec; 9(6):279-83. PMID: 2286018.
      View in: PubMed
    325. Rippe DJ, Boyko OB, Fuller GN, Friedman HS, Oakes WJ, Schold SC. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination. AJNR Am J Neuroradiol. 1990 Jul-Aug; 11(4):800-1. PMID: 2114771.
      View in: PubMed
    326. Zalutsky MR, Moseley RP, Benjamin JC, Colapinto EV, Fuller GN, Coakham HP, Bigner DD. Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration. Cancer Res. 1990 Jul 01; 50(13):4105-10. PMID: 2162252.
      View in: PubMed
    327. Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci U S A. 1990 Jun; 87(11):4207-11. PMID: 1693434.
      View in: PubMed
    328. Fuchs HE, Archer GE, Colvin OM, Bigner SH, Schuster JM, Fuller GN, Muhlbaier LH, Schold SC, Friedman HS, Bigner DD. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis. Cancer Res. 1990 Mar 15; 50(6):1954-9. PMID: 2306744.
      View in: PubMed
    329. Wolf HK, Anthony DC, Fuller GN. Arterial border zone necrosis of the spinal cord. Clin Neuropathol. 1990 Mar-Apr; 9(2):60-5. PMID: 2187639.
      View in: PubMed
    330. Fuller GN, Jacobs JM, Guiloff RJ. Axonal atrophy in the painful peripheral neuropathy in AIDS. Acta Neuropathol. 1990; 81(2):198-203. PMID: 1964527.
      View in: PubMed
    331. Fuller GN, Guiloff RJ, Gazzard B, Harcourt-Webster JN, Scarvilli F. Neurological presentations of AIDS--when to test for HIV. J R Soc Med. 1989 Dec; 82(12):717-20. PMID: 2614762.
      View in: PubMed
    332. Fuller GN, Rea AJ, Payne JF, Lant AF. Parasuicide in central London 1984-1988. J R Soc Med. 1989 Nov; 82(11):653-6. PMID: 2574238.
      View in: PubMed
    333. Moul JW, Paulson DF, Fuller G, Gottfried MR, Floyd WL. Prostate cancer with solitary parotid metastasis correctly diagnosed with immunohistochemical stains. J Urol. 1989 Nov; 142(5):1328-9. PMID: 2478728.
      View in: PubMed
    334. Uglietta JP, Boyko OB, Rippe DJ, Fuller GN, Schiff SJ, Heinz ER. Intracerebral extension of nasal dermoid cyst: CT appearance. J Comput Assist Tomogr. 1989 Nov-Dec; 13(6):1061-4. PMID: 2584485.
      View in: PubMed
    335. Noormohamed FH, Fuller GN, Lant AF. Effect of salt balance on the renal and hemodynamic actions of benazepril in normal men. J Clin Pharmacol. 1989 Oct; 29(10):928-37. PMID: 2687336.
      View in: PubMed
    336. Rippe DJ, Grist TM, Uglietta JP, Fuller GN, Boyko OB. Carotid body tumor: flow sensitive pulse sequences and MR angiography. J Comput Assist Tomogr. 1989 Sep-Oct; 13(5):874-7. PMID: 2778145.
      View in: PubMed
    337. Fuller GN, Guiloff RJ, Scaravilli F, Harcourt-Webster JN. Combined HIV-CMV encephalitis presenting with brainstem signs. J Neurol Neurosurg Psychiatry. 1989 Aug; 52(8):975-9. PMID: 2552024.
      View in: PubMed
    338. Fuller GN, Jacobs JM. Cytomembranous inclusions in the peripheral nerves in AIDS. Acta Neuropathol. 1989; 79(3):336-9. PMID: 2558489.
      View in: PubMed
    339. Alston SR, Fuller GN, Boyko OB, Goscin SA, DiSclafani A. Ectopic immature renal tissue in a lumbosacral lipoma: pathologic and radiologic findings. Pediatr Neurosci. 1989; 15(2):100-3. PMID: 2635297.
      View in: PubMed
    340. Guiloff RJ, Fuller GN, Roberts A, Hargreaves M, Gazzard B, Scaravilli F, Harcourt-Webster JN. Nature, incidence and prognosis of neurological involvement in the acquired immunodeficiency syndrome in central London. Postgrad Med J. 1988 Dec; 64(758):919-25. PMID: 2855752.
      View in: PubMed
    341. Fuller GN, Journeaux SF, Corner K, Lant AF. The risks of staying in London: a review of overseas visitors admitted to a London hospital. J R Soc Med. 1988 May; 81(5):267-9. PMID: 3385712.
      View in: PubMed
    342. Fuller GN, Lin SN, Caprioli RM, Wiggins RC, Dafny N. Dose-related differential accumulation of morphine in specific regions of rat brain determined by mass fragmentography. Int J Neurosci. 1988 Jan; 38(1-2):31-8. PMID: 3356502.
      View in: PubMed
    343. Burchiel SW, Pollock RR, Covell DG, Fuller G, Scharff MD. Pharmacokinetic analysis of biosynthetically radiolabeled mouse monoclonal antibodies in normal rhesus monkeys. Int J Immunopharmacol. 1987; 9(8):913-8. PMID: 3429078.
      View in: PubMed
    344. Fuller GN, Rigor BM, Wiggins RC, Dafny N. Prolonged daily inhalation of halothane modifies the dose-response pattern to acute administration of halothane. An electrophysiological study. Neuropharmacology. 1985 Nov; 24(11):1033-8. PMID: 4080102.
      View in: PubMed
    345. Wiggins RC, Fuller G, Enna SJ. Undernutrition and the development of brain neurotransmitter systems. Life Sci. 1984 Nov 19; 35(21):2085-94. PMID: 6149444.
      View in: PubMed
    346. Telang S, Fuller G, Wiggins R, Enna SJ. Early undernutrition and [3H]gamma-aminobutyric acid binding in rat brain. J Neurochem. 1984 Sep; 43(3):640-5. PMID: 6086836.
      View in: PubMed
    347. Wiggins RC, Fuller GN, Brizzee L, Bissel AC, Samorajski T. Myelination of the rat optic nerve during postnatal undernourishment and recovery: a morphometric analysis. Brain Res. 1984 Aug 13; 308(2):263-72. PMID: 6478208.
      View in: PubMed
    348. Fuller GN, Wiggins RC. Differential growth recovery within the brains of postnatally undernourished rats. Brain Res. 1984 Aug; 317(2):280-2. PMID: 6478252.
      View in: PubMed
    349. Fuller GN, Wiggins RC. Brain hypomyelination during postnatal undernourishment: a comparison of proteolipid protein synthesis versus assembly into membrane. Exp Neurol. 1984 May; 84(2):306-13. PMID: 6714344.
      View in: PubMed
    350. Fuller GN, Johnston DA, Wiggins RC. The relationship between nutritional adequacy and brain myelin accumulation: a comparison of varying degrees of well fed and undernourished rats. Brain Res. 1984 Jan 02; 290(1):195-8. PMID: 6419986.
      View in: PubMed
    351. Fuller GN, Bell ME, Wiggins RC. Postnatal increase in the metabolism of leucine and valine. Biol Neonate. 1983; 44(5):295-302. PMID: 6639999.
      View in: PubMed
    352. Fuller GN, Divakaran P, Wiggins RC. The effect of postnatal caffeine administration on brain myelination. Brain Res. 1982 Oct 07; 249(1):189-91. PMID: 7139294.
      View in: PubMed
    353. Wiggins RC, Fuller GN, Dafny N. Propagation of photic evoked responses recorded from the retina, optic chiasm, lateral geniculate body, and visual cortex of the nutritionally rehabilitated rat visual system. Exp Neurol. 1982 Sep; 77(3):644-53. PMID: 7117468.
      View in: PubMed
    354. Wiggins RC, Fuller GN, Seifert WE, Butler IJ, Gottesfeld Z. Catecholamines in rat brain following postnatal undernutrition and nutritional rehabilitation. J Neurosci Res. 1982; 8(4):651-6. PMID: 7161844.
      View in: PubMed
    355. Fuller GN, Chentanez T, Wiggins RC, Dafny N. Ethanol-induced modification of sensory evoked potentials recorded from the caudate nucleus, substantia nigra, hypothalamus, and pineal. Neuropharmacology. 1981 Sep; 20(9):861-7. PMID: 7290358.
      View in: PubMed
    356. Wiggins RC, Fuller GN. Analysis of distribution of rat sciatic nerve protein among soluble, insoluble, and myelin subfraction. Neurochem Res. 1981 Jun; 6(6):719-27. PMID: 7279118.
      View in: PubMed
    357. Fuller GN, Wiggins RC. A possible effect of the methylxanthines caffeine, theophylline and aminophylline on postnatal myelination of the rat brain. Brain Res. 1981 Jun 01; 213(2):476-80. PMID: 7248772.
      View in: PubMed
    358. Sikes RW, Fuller GN, Colbert C, Chronister RB, DeFrance J, Wiggins RC. The relative numbers of oligodendroglia in different brain regions of normal and postnatally undernourished rats. Brain Res Bull. 1981 May; 6(5):385-91. PMID: 6788349.
      View in: PubMed
    359. Delaney AJ, Samorajski T, Fuller GN, Wiggins RC. A morphometric comparison of central and peripheral hypomyelination induced by postnatal undernourishment of rats. J Nutr. 1981 Apr; 111(4):746-54. PMID: 7218045.
      View in: PubMed
    360. Gottesfeld Z, Fuller GN, Wiggins RC. Adrenergic neuroplasticity is maintained in the nutritional rehabilitated adult rat. Experientia. 1981 Feb 15; 37(2):168-9. PMID: 7238746.
      View in: PubMed
    361. Reilly EL, Fuller GN, Wiggins RC, Rigor BM, Dafny N. Chronic halothane modification of eeg-like activity recorded from somatosensory cortex and deep nuclei in freely behaving rats. Neurotoxicology. 1981 Jan; 2(1):83-90. PMID: 15622727.
      View in: PubMed
    362. Wiggins RC, Fuller GN, Dafny N. The electroretinogram of adult rats following a period of postnatal undernutrition and prolonged nutritional rehabilitation. Life Sci. 1980 Apr 07; 26(14):1169-74. PMID: 7392794.
      View in: PubMed
    363. Taber KH, Fuller GN, Stanley JC, DeFrance JF, Wiggins RC. The effect of postnatal undernourishment on epileptiform kindling of dorsal hippocampus. Experientia. 1980 Jan 15; 36(1):69-70. PMID: 7358137.
      View in: PubMed
    364. Fuller GN, Rigor BM, Wiggins RC, Dafny N. Does chronic halothane exposure alter brain electrical activity? Sensory evoked potentials recorded from cortex, diencephalon, and mesencephalon in freely behaving rats. Subst Alcohol Actions Misuse. 1980; 1(1):35-42. PMID: 7323942.
      View in: PubMed
    365. Wiggins RC, Fuller GN, Astrello JM, Rigor BM. Decreased myelin synthesis in developing rats following repeated pre- and perinatal exposure to subanesthetic amounts of halothane. J Neurochem. 1979 Jul; 33(1):361-3. PMID: 458464.
      View in: PubMed
    366. Wiggins RC, Fuller GN, Bell ME. Incorporation of leucine metabolites into brain and sciatic nerve myelin. J Neurochem. 1979 May; 32(5):1579-82. PMID: 438825.
      View in: PubMed
    367. Wiggins RC, Fuller GN. Relative synthesis of myelin in different brain regions of postnatally undernourished rats. Brain Res. 1979 Feb 16; 162(1):103-12. PMID: 761075.
      View in: PubMed
    368. Wiggins RC, Fuller GN. Early postnatal starvation causes lasting brain hypomyelination. J Neurochem. 1978 Jun; 30(6):1231-7. PMID: 670966.
      View in: PubMed
    369. Ooshima A, Fuller G, Cardinale G, Spector S, Udenfriend S. Collagen biosynthesis in blood vessels of brain and other tissues of the hypertensive rat. Science. 1975 Nov 28; 190(4217):898-900. PMID: 171771.
      View in: PubMed
    370. Comparison of the invasiveness profiles of en plaque and globoid meningiomas. Skull Base Surgery. 9:7.
    371. Introduction. Brain Pathology. 12:53.
    372. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum. American Journal of Surgical Pathology.
    373. Finding functional structures in glioma gene-expressions using gene shaving clustering and MDL principle. 89-118.
    374. Central nervous system.
    375. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 167:1281-1295.e18.
    376. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathologica. 130:587-597.
    377. Progressive diffuse meningioangiomatosis. Neurology. 86:1643-1644.
    378. Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics. 3.
    379. Brain Metastases. 55-70.
    380. Whole-transcriptome analysis of chordoma of the skull base. Virchows Archiv. 1-11.
    381. Tumor-associated methylation of the putative tumor suppressor ajap1 gene and association between decreased ajap1 expression and shorter survival in patients with glioma. Chinese Journal of Cancer. 30:254-263.
    382. IGFBP2 potentiates nuclear EGFR-STAT3 signaling. Oncogene. 35:738-747.
    383. PD-L1 expression and prognostic impact in glioblastoma. Neuro-Oncology. 18:195-205.
    384. Erratum to. Journal of Neuro-Oncology. 119:37.
    385. Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma. Oncotarget. 7:26793-26805.
    386. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro-Oncology. 18:639-648.
    387. miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis. Cancer Research. 76:4293-4304.
    388. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nature Genetics. 49:75-86.
    389. REST regulates oncogenic properties of glioblastoma stem cells (Stem Cells (2012) 30 (405-414) DOI. Stem Cells. 30:1049.
    390. Sarcoma Brain Metastases. Annals of Surgical Oncology. 1-6.
    391. The 2007 WHO classification of tumors of the nervous system. Brain Pathology. 18:640.
    392. Epithelial, Neuroendocrine, and Metastatic Lesions. 287-313.
    393. Differential growth recovery within the brains of postnatally undernourished rats. Developmental Brain Research. 15:280-282.
    394. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. Journal of Neuro-Oncology. 1-8.
    395. Molecular diagnosis of glioma. 520-527.
    396. Gliomatosis peritonei. Modern Pathology. 1613-1620.
    397. Immune checkpoint blockade as a potential therapeutic target. Neuro-Oncology. 18:1357-1366.
    398. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Oncotarget. 7:23521-23529.
    399. Intraoperative Consultation and Optimal Processing. 35-45.
    400. Brain tumors. Archives of Pathology and Laboratory Medicine. 131:225-227.
    401. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. American Journal of Hematology. 92:155-160.
    402. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. OncoImmunology.
    403. The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation. Oncogene.
    404. PINK1 is a negative regulator of growth and the warburg effect in glioblastoma. Cancer Research. 76:4708-4719.
    405. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutation Research - Reviews in Mutation Research. 276:299-306.
    406. Mitotic index is an independent predictor of recurrence-free survival in meningioma. Brain Pathology. 25:266-275.
    407. Mir-21-Sox2 axis delineates glioblastoma subtypes with prognostic impact. Journal of Neuroscience. 35:15097-15112.
    FULLER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description